Your browser doesn't support javascript.
loading
RSK2 promotes melanoma cell proliferation and vemurafenib resistance via upregulating cyclin D1.
Wu, Hai-Zhou; Li, Lan-Ya; Jiang, Shi-Long; Li, Yi-Zhi; Shi, Xiao-Mei; Sun, Xin-Yuan; Li, Zhuo; Cheng, Yan.
Afiliação
  • Wu HZ; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Li LY; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
  • Jiang SL; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Li YZ; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
  • Shi XM; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Sun XY; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Li Z; Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, China.
  • Cheng Y; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Front Pharmacol ; 13: 950571, 2022.
Article em En | MEDLINE | ID: mdl-36210843
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China